Ancora Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Ancora Advisors's ELV Position: Q1 2026 in Review
Ancora Advisors increased its Elevance Health (ELV) stake by 57% in Q1 2026, buying an estimated $49.3K and bringing the position to 414 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #860.
Ancora Advisors first reported a position in ELV in Q3 2018 and has held it in 27 quarters since. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Ancora Advisors held 414 shares of Elevance Health worth $121K as of Q1 2026.
- Ancora Advisors bought 150 Elevance Health shares in Q1 2026, an estimated $49.3K.
- Elevance Health made up ﹤0.01% of Ancora Advisors's portfolio in Q1 2026, its #860 holding.
- Ancora Advisors first reported a position in Elevance Health in Q3 2018 and has held it in 27 quarters since.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.